Computational Medicine and Drug Designing Software Market, Global Outlook and Forecast 2023-2029

Report ID: MMG17205 | Category: Service & Software | Pages: 107 | Format: PDF | Published Date: February 20,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for Computational Medicine and Drug Designing Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computational Medicine and Drug Designing Software. This report contains market size and forecasts of Computational Medicine and Drug Designing Software in global, including the following market information:
Global Computational Medicine and Drug Designing Software Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Computational Medicine and Drug Designing Software market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Cloud-based Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Computational Medicine and Drug Designing Software include Entelos, Crown Bioscience, Chemical Computing Group, Nimbus Therapeutics, Schrodinger, Dassault Systemes, Genedata, Biognos and Leadscope, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Computational Medicine and Drug Designing Software companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Computational Medicine and Drug Designing Software Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Computational Medicine and Drug Designing Software Market Segment Percentages, by Type, 2022 (%)
    Cloud-based
    On-premise
Global Computational Medicine and Drug Designing Software Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Computational Medicine and Drug Designing Software Market Segment Percentages, by Application, 2022 (%)
    Drug Discovery and Development
    Computational Physiological Medicine
    Disease Modeling
    Medical Imaging
    Predictive Analysis of Drug Targets
Global Computational Medicine and Drug Designing Software Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Computational Medicine and Drug Designing Software Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Computational Medicine and Drug Designing Software revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Computational Medicine and Drug Designing Software revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Entelos
    Crown Bioscience
    Chemical Computing Group
    Nimbus Therapeutics
    Schrodinger
    Dassault Systemes
    Genedata
    Biognos
    Leadscope
    Rhenovia Pharma Limited
    Compugen
    Certara LP
    Prosarix
    Simulations Plus
    Strand Life Sciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Computational Medicine and Drug Designing Software, market overview.
Chapter 2: Global Computational Medicine and Drug Designing Software market size in revenue.
Chapter 3: Detailed analysis of Computational Medicine and Drug Designing Software company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Computational Medicine and Drug Designing Software in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Computational Medicine and Drug Designing Software Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Computational Medicine and Drug Designing Software Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Computational Medicine and Drug Designing Software Overall Market Size
    2.1 Global Computational Medicine and Drug Designing Software Market Size: 2022 VS 2029
    2.2 Global Computational Medicine and Drug Designing Software Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Computational Medicine and Drug Designing Software Players in Global Market
    3.2 Top Global Computational Medicine and Drug Designing Software Companies Ranked by Revenue
    3.3 Global Computational Medicine and Drug Designing Software Revenue by Companies
    3.4 Top 3 and Top 5 Computational Medicine and Drug Designing Software Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Computational Medicine and Drug Designing Software Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Computational Medicine and Drug Designing Software Players in Global Market
        3.6.1 List of Global Tier 1 Computational Medicine and Drug Designing Software Companies
        3.6.2 List of Global Tier 2 and Tier 3 Computational Medicine and Drug Designing Software Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Computational Medicine and Drug Designing Software Market Size Markets, 2022 & 2029
        4.1.2 Cloud-based
        4.1.3 On-premise
    4.2 By Type - Global Computational Medicine and Drug Designing Software Revenue & Forecasts
        4.2.1 By Type - Global Computational Medicine and Drug Designing Software Revenue, 2018-2023
        4.2.2 By Type - Global Computational Medicine and Drug Designing Software Revenue, 2024-2029
        4.2.3 By Type - Global Computational Medicine and Drug Designing Software Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Computational Medicine and Drug Designing Software Market Size, 2022 & 2029
        5.1.2 Drug Discovery and Development
        5.1.3 Computational Physiological Medicine
        5.1.4 Disease Modeling
        5.1.5 Medical Imaging
        5.1.6 Predictive Analysis of Drug Targets
    5.2 By Application - Global Computational Medicine and Drug Designing Software Revenue & Forecasts
        5.2.1 By Application - Global Computational Medicine and Drug Designing Software Revenue, 2018-2023
        5.2.2 By Application - Global Computational Medicine and Drug Designing Software Revenue, 2024-2029
        5.2.3 By Application - Global Computational Medicine and Drug Designing Software Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Computational Medicine and Drug Designing Software Market Size, 2022 & 2029
    6.2 By Region - Global Computational Medicine and Drug Designing Software Revenue & Forecasts
        6.2.1 By Region - Global Computational Medicine and Drug Designing Software Revenue, 2018-2023
        6.2.2 By Region - Global Computational Medicine and Drug Designing Software Revenue, 2024-2029
        6.2.3 By Region - Global Computational Medicine and Drug Designing Software Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Computational Medicine and Drug Designing Software Revenue, 2018-2029
        6.3.2 US Computational Medicine and Drug Designing Software Market Size, 2018-2029
        6.3.3 Canada Computational Medicine and Drug Designing Software Market Size, 2018-2029
        6.3.4 Mexico Computational Medicine and Drug Designing Software Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Computational Medicine and Drug Designing Software Revenue, 2018-2029
        6.4.2 Germany Computational Medicine and Drug Designing Software Market Size, 2018-2029
        6.4.3 France Computational Medicine and Drug Designing Software Market Size, 2018-2029
        6.4.4 U.K. Computational Medicine and Drug Designing Software Market Size, 2018-2029
        6.4.5 Italy Computational Medicine and Drug Designing Software Market Size, 2018-2029
        6.4.6 Russia Computational Medicine and Drug Designing Software Market Size, 2018-2029
        6.4.7 Nordic Countries Computational Medicine and Drug Designing Software Market Size, 2018-2029
        6.4.8 Benelux Computational Medicine and Drug Designing Software Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Computational Medicine and Drug Designing Software Revenue, 2018-2029
        6.5.2 China Computational Medicine and Drug Designing Software Market Size, 2018-2029
        6.5.3 Japan Computational Medicine and Drug Designing Software Market Size, 2018-2029
        6.5.4 South Korea Computational Medicine and Drug Designing Software Market Size, 2018-2029
        6.5.5 Southeast Asia Computational Medicine and Drug Designing Software Market Size, 2018-2029
        6.5.6 India Computational Medicine and Drug Designing Software Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Computational Medicine and Drug Designing Software Revenue, 2018-2029
        6.6.2 Brazil Computational Medicine and Drug Designing Software Market Size, 2018-2029
        6.6.3 Argentina Computational Medicine and Drug Designing Software Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Computational Medicine and Drug Designing Software Revenue, 2018-2029
        6.7.2 Turkey Computational Medicine and Drug Designing Software Market Size, 2018-2029
        6.7.3 Israel Computational Medicine and Drug Designing Software Market Size, 2018-2029
        6.7.4 Saudi Arabia Computational Medicine and Drug Designing Software Market Size, 2018-2029
        6.7.5 UAE Computational Medicine and Drug Designing Software Market Size, 2018-2029
7 Computational Medicine and Drug Designing Software Companies Profiles
    7.1 Entelos
        7.1.1 Entelos Company Summary
        7.1.2 Entelos Business Overview
        7.1.3 Entelos Computational Medicine and Drug Designing Software Major Product Offerings
        7.1.4 Entelos Computational Medicine and Drug Designing Software Revenue in Global Market (2018-2023)
        7.1.5 Entelos Key News & Latest Developments
    7.2 Crown Bioscience
        7.2.1 Crown Bioscience Company Summary
        7.2.2 Crown Bioscience Business Overview
        7.2.3 Crown Bioscience Computational Medicine and Drug Designing Software Major Product Offerings
        7.2.4 Crown Bioscience Computational Medicine and Drug Designing Software Revenue in Global Market (2018-2023)
        7.2.5 Crown Bioscience Key News & Latest Developments
    7.3 Chemical Computing Group
        7.3.1 Chemical Computing Group Company Summary
        7.3.2 Chemical Computing Group Business Overview
        7.3.3 Chemical Computing Group Computational Medicine and Drug Designing Software Major Product Offerings
        7.3.4 Chemical Computing Group Computational Medicine and Drug Designing Software Revenue in Global Market (2018-2023)
        7.3.5 Chemical Computing Group Key News & Latest Developments
    7.4 Nimbus Therapeutics
        7.4.1 Nimbus Therapeutics Company Summary
        7.4.2 Nimbus Therapeutics Business Overview
        7.4.3 Nimbus Therapeutics Computational Medicine and Drug Designing Software Major Product Offerings
        7.4.4 Nimbus Therapeutics Computational Medicine and Drug Designing Software Revenue in Global Market (2018-2023)
        7.4.5 Nimbus Therapeutics Key News & Latest Developments
    7.5 Schrodinger
        7.5.1 Schrodinger Company Summary
        7.5.2 Schrodinger Business Overview
        7.5.3 Schrodinger Computational Medicine and Drug Designing Software Major Product Offerings
        7.5.4 Schrodinger Computational Medicine and Drug Designing Software Revenue in Global Market (2018-2023)
        7.5.5 Schrodinger Key News & Latest Developments
    7.6 Dassault Systemes
        7.6.1 Dassault Systemes Company Summary
        7.6.2 Dassault Systemes Business Overview
        7.6.3 Dassault Systemes Computational Medicine and Drug Designing Software Major Product Offerings
        7.6.4 Dassault Systemes Computational Medicine and Drug Designing Software Revenue in Global Market (2018-2023)
        7.6.5 Dassault Systemes Key News & Latest Developments
    7.7 Genedata
        7.7.1 Genedata Company Summary
        7.7.2 Genedata Business Overview
        7.7.3 Genedata Computational Medicine and Drug Designing Software Major Product Offerings
        7.7.4 Genedata Computational Medicine and Drug Designing Software Revenue in Global Market (2018-2023)
        7.7.5 Genedata Key News & Latest Developments
    7.8 Biognos
        7.8.1 Biognos Company Summary
        7.8.2 Biognos Business Overview
        7.8.3 Biognos Computational Medicine and Drug Designing Software Major Product Offerings
        7.8.4 Biognos Computational Medicine and Drug Designing Software Revenue in Global Market (2018-2023)
        7.8.5 Biognos Key News & Latest Developments
    7.9 Leadscope
        7.9.1 Leadscope Company Summary
        7.9.2 Leadscope Business Overview
        7.9.3 Leadscope Computational Medicine and Drug Designing Software Major Product Offerings
        7.9.4 Leadscope Computational Medicine and Drug Designing Software Revenue in Global Market (2018-2023)
        7.9.5 Leadscope Key News & Latest Developments
    7.10 Rhenovia Pharma Limited
        7.10.1 Rhenovia Pharma Limited Company Summary
        7.10.2 Rhenovia Pharma Limited Business Overview
        7.10.3 Rhenovia Pharma Limited Computational Medicine and Drug Designing Software Major Product Offerings
        7.10.4 Rhenovia Pharma Limited Computational Medicine and Drug Designing Software Revenue in Global Market (2018-2023)
        7.10.5 Rhenovia Pharma Limited Key News & Latest Developments
    7.11 Compugen
        7.11.1 Compugen Company Summary
        7.11.2 Compugen Business Overview
        7.11.3 Compugen Computational Medicine and Drug Designing Software Major Product Offerings
        7.11.4 Compugen Computational Medicine and Drug Designing Software Revenue in Global Market (2018-2023)
        7.11.5 Compugen Key News & Latest Developments
    7.12 Certara LP
        7.12.1 Certara LP Company Summary
        7.12.2 Certara LP Business Overview
        7.12.3 Certara LP Computational Medicine and Drug Designing Software Major Product Offerings
        7.12.4 Certara LP Computational Medicine and Drug Designing Software Revenue in Global Market (2018-2023)
        7.12.5 Certara LP Key News & Latest Developments
    7.13 Prosarix
        7.13.1 Prosarix Company Summary
        7.13.2 Prosarix Business Overview
        7.13.3 Prosarix Computational Medicine and Drug Designing Software Major Product Offerings
        7.13.4 Prosarix Computational Medicine and Drug Designing Software Revenue in Global Market (2018-2023)
        7.13.5 Prosarix Key News & Latest Developments
    7.14 Simulations Plus
        7.14.1 Simulations Plus Company Summary
        7.14.2 Simulations Plus Business Overview
        7.14.3 Simulations Plus Computational Medicine and Drug Designing Software Major Product Offerings
        7.14.4 Simulations Plus Computational Medicine and Drug Designing Software Revenue in Global Market (2018-2023)
        7.14.5 Simulations Plus Key News & Latest Developments
    7.15 Strand Life Sciences
        7.15.1 Strand Life Sciences Company Summary
        7.15.2 Strand Life Sciences Business Overview
        7.15.3 Strand Life Sciences Computational Medicine and Drug Designing Software Major Product Offerings
        7.15.4 Strand Life Sciences Computational Medicine and Drug Designing Software Revenue in Global Market (2018-2023)
        7.15.5 Strand Life Sciences Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Computational Medicine and Drug Designing Software Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?